Tag: AHSCT

It is important for people with MS to have the best available information on stem cell therapy to make decisions related to this complex issue.

Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS

Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other MS therapies have been presented at a Lisbon conference.